Literature DB >> 8825627

The genetic mapping and gene structure of mouse paraoxonase/arylesterase.

R C Sorenson1, S L Primo-Parmo, S A Camper, B N La Du.   

Abstract

The physiological role of mammalian paraoxonase/arylesterase is unknown. However, paraoxonase is an HDL-associated protein, and recent studies indicate that it may have anti-atherogenic functions. We describe the chromosomal localization and structure of the mouse paraoxonase gene (Pon1) to establish Pon1 as a candidate gene for genetically determined traits or pathological states in the mouse. The coding portion of Pon1 extends over approximately 25-26 kb and consists of nine exons and eight introns. We also present nucleotide sequences from the 5'-flanking region of Pon1 containing numerous consensus sequences for DNA binding proteins. Haplotype analysis of 94 N2 progeny from an interspecific cross indicates that Pon1 is localized on proximal mouse chromosome 6 near D6Mit86. This assignment excludes Pon1 as a candidate for the atherosclerosis susceptibility genes Ath1, Ath2, and Ath3. However, Pon1 is a promising candidate for the remaining unmapped Ath genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8825627     DOI: 10.1006/geno.1995.1261

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  13 in total

1.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

Review 2.  Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria.

Authors:  Jordi Camps; Isabel Pujol; Frederic Ballester; Jorge Joven; Josep M Simó
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

3.  Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase.

Authors:  Yu Yang; Yanrong Zhang; Santiago Cuevas; Van Anthony Villar; Crisanto Escano; Laureano D Asico; Peiying Yu; David K Grandy; Robin A Felder; Ines Armando; Pedro A Jose
Journal:  Free Radic Biol Med       Date:  2012-05-23       Impact factor: 7.376

4.  Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based study.

Authors:  Gerard Aragonès; Marta Guardiola; María Barreda; Judit Marsillach; Raúl Beltrán-Debón; Anna Rull; Bharti Mackness; Michael Mackness; Jorge Joven; Josep M Simó; Jordi Camps
Journal:  J Lipid Res       Date:  2011-02-17       Impact factor: 5.922

Review 5.  Pharmacogenetics of paraoxonases: a brief review.

Authors:  D I Draganov; B N La Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-25       Impact factor: 3.000

Review 6.  Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.

Authors:  Ayman Samir Farid; Yoichiro Horii
Journal:  Lipids Health Dis       Date:  2012-07-23       Impact factor: 3.876

7.  PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways.

Authors:  Jordi Camps; Anabel García-Heredia; Anna Rull; Carlos Alonso-Villaverde; Gerard Aragonès; Raúl Beltrán-Debón; Esther Rodríguez-Gallego; Jorge Joven
Journal:  PPAR Res       Date:  2012-01-24       Impact factor: 4.964

8.  Immunohistochemical analysis of paraoxonases and chemokines in arteries of patients with peripheral artery disease.

Authors:  Anna Hernández-Aguilera; Julio Sepúlveda; Esther Rodríguez-Gallego; Maria Guirro; Anabel García-Heredia; Noemí Cabré; Fedra Luciano-Mateo; Isabel Fort-Gallifa; Vicente Martín-Paredero; Jorge Joven; Jordi Camps
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

Review 9.  Exploring the role of paraoxonases in the pathogenesis of coronary artery disease: a systematic review.

Authors:  David Abelló; Elena Sancho; Jordi Camps; Jorge Joven
Journal:  Int J Mol Sci       Date:  2014-11-14       Impact factor: 5.923

10.  An Engineered Version of Human PON2 Opens the Way to Understand the Role of Its Post-Translational Modifications in Modulating Catalytic Activity.

Authors:  Luigi Mandrich; Mariangela Cerreta; Giuseppe Manco
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.